EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.872
https://www.valueinhealthjournal.com/article/S1098-3015(24)00987-2/fulltext
Title :
EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00987-2&doi=10.1016/j.jval.2024.03.872
First page :
Section Title :
Open access? :
No
Section Order :
10322